Amanote Research

Amanote Research

    RegisterSign In

Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

BioMed Research International - United States
doi 10.1155/2019/8298192
Full Text
Open PDF
Abstract

Available in full text

Categories
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
Date

October 9, 2019

Authors
Apostolos E. PapaloisCalypso BarbatisDimosthenis ChrysikosMaria KorontziMichail SiderisTheodoros PittarasEleni TriantafyllidiAlexandros NomikosJohn K. Triantafillidis
Publisher

Hindawi Limited


Related search

Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1991English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1994English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1990English

Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF; CSF2)

Science-Business eXchange
2012English

Granulocyte-Macrophage Colony Stimulating Factor

Reactions Weekly
1995English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1992English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1991English

Granulocyte-Macrophage Colony-Stimulating Factor

Reactions Weekly
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy